BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38657558)

  • 1. Curcumin-loaded liposomes modulating the synergistic role of EpCAM and estrogen receptor alpha in lung cancer management.
    Singh M; De Rubis G; Kokkinis S; Paudel KR; Yeung S; Hansbro PM; Oliver BGG; Dua K
    Pathol Res Pract; 2024 May; 257():155317. PubMed ID: 38657558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
    Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
    Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines.
    Baharuddin P; Satar N; Fakiruddin KS; Zakaria N; Lim MN; Yusoff NM; Zakaria Z; Yahaya BH
    Oncol Rep; 2016 Jan; 35(1):13-25. PubMed ID: 26531053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations.
    Tang C; Liu J; Yang C; Ma J; Chen X; Liu D; Zhou Y; Zhou W; Lin Y; Yuan X
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer.
    Mariscal J; Alonso-Nocelo M; Muinelo-Romay L; Barbazan J; Vieito M; Abalo A; Gomez-Tato A; Maria de Los Angeles CC; Garcia-Caballero T; Rodriguez C; Brozos E; Baron F; Lopez-Lopez R; Abal M
    Sci Rep; 2016 Nov; 6():37820. PubMed ID: 27901069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine.
    Hong Y; Che S; Hui B; Wang X; Zhang X; Ma H
    Drug Des Devel Ther; 2020; 14():2263-2274. PubMed ID: 32606596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin loaded sub-30 nm targeting therapeutic lipid nanoparticles for synergistically blocking nasopharyngeal cancer growth and metastasis.
    Luo H; Lu L; Liu N; Li Q; Yang X; Zhang Z
    J Nanobiotechnology; 2021 Jul; 19(1):224. PubMed ID: 34320999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells.
    Wang YJ; Tang L; Lu XH; Liu JT; Wang YY; Geng HX; Li XT; An Q
    J Liposome Res; 2023 Jun; 33(2):197-213. PubMed ID: 36440599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A).
    Khan MN; Haggag YA; Lane ME; McCarron PA; Tambuwala MM
    Curr Drug Deliv; 2018 Feb; 15(2):286-295. PubMed ID: 29065834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
    Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
    Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway.
    Liao ZJ; Guo YH; Zhao Z; Yao JT; Xu R; Nan KJ
    Int J Oncol; 2014 Aug; 45(2):651-8. PubMed ID: 24867356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
    Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway.
    Xu X; Zhang X; Zhang Y; Wang Z
    Biomed Pharmacother; 2021 Jun; 138():111439. PubMed ID: 33684690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits the growth via Wnt/β-catenin pathway in non-small-cell lung cancer cells.
    Wang JY; Wang X; Wang XJ; Zheng BZ; Wang Y; Wang X; Liang B
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7492-7499. PubMed ID: 30468498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Curcumin in Comparison with Trichostatin A on the Reactivation of Estrogen Receptor Alpha gene Expression, Cell Growth Inhibition and Apoptosis Induction in Hepatocellular Carcinoma Hepa 1-6 Cell lLine.
    Sanaei M; Kavoosi F; Arabloo M
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):1045-1050. PubMed ID: 32334468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles.
    Jiang S; Zhu R; He X; Wang J; Wang M; Qian Y; Wang S
    Int J Nanomedicine; 2017; 12():167-178. PubMed ID: 28053531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma.
    Salehi M; Movahedpour A; Tayarani A; Shabaninejad Z; Pourhanifeh MH; Mortezapour E; Nickdasti A; Mottaghi R; Davoodabadi A; Khan H; Savardashtaki A; Mirzaei H
    Phytother Res; 2020 Oct; 34(10):2557-2576. PubMed ID: 32307773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways.
    He M; Yu W; Chang C; Miyamoto H; Liu X; Jiang K; Yeh S
    Mol Oncol; 2020 Aug; 14(8):1779-1799. PubMed ID: 32356397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor-alpha isoforms are the main estrogen receptors expressed in non-small cell lung carcinoma.
    Pelekanou V; Anastasiou E; Bakogeorgou E; Notas G; Kampa M; Garcia-Milian R; Lavredaki K; Moustou E; Chinari G; Arapantoni P; O'Grady A; Georgoulias V; Tsapis A; Stathopoulos EN; Castanas E
    Steroids; 2019 Feb; 142():65-76. PubMed ID: 29454903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.
    Lee JY; Lee YM; Chang GC; Yu SL; Hsieh WY; Chen JJ; Chen HW; Yang PC
    PLoS One; 2011; 6(8):e23756. PubMed ID: 21858220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.